KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 79 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,673 | -5.1% | 22,144 | +26.8% | 0.00% | 0.0% |
| Q2 2023 | $31,264 | +41585.3% | 17,466 | -9.7% | 0.00% | -50.0% |
| Q1 2023 | $75 | +8.7% | 19,343 | -3.9% | 0.00% | -33.3% |
| Q4 2022 | $69 | -100.0% | 20,122 | -41.5% | 0.00% | 0.0% |
| Q3 2022 | $188,000 | +43.5% | 34,397 | +18.2% | 0.00% | 0.0% |
| Q2 2022 | $131,000 | +172.9% | 29,096 | +346.3% | 0.00% | – |
| Q1 2022 | $48,000 | -62.2% | 6,520 | -67.0% | 0.00% | -100.0% |
| Q4 2021 | $127,000 | -16.4% | 19,738 | -24.1% | 0.00% | -50.0% |
| Q3 2021 | $152,000 | +176.4% | 26,001 | +383.6% | 0.00% | +300.0% |
| Q2 2021 | $55,000 | -82.6% | 5,377 | -82.1% | 0.00% | -80.0% |
| Q1 2021 | $316,000 | -37.4% | 30,032 | -8.0% | 0.01% | -66.7% |
| Q4 2020 | $505,000 | +448.9% | 32,634 | +418.6% | 0.02% | +1400.0% |
| Q3 2020 | $92,000 | -60.5% | 6,293 | -48.9% | 0.00% | -90.0% |
| Q2 2020 | $233,000 | +161.8% | 12,312 | +165.1% | 0.01% | +42.9% |
| Q4 2019 | $89,000 | +161.8% | 4,645 | +33.6% | 0.01% | +250.0% |
| Q3 2019 | $34,000 | +1033.3% | 3,476 | +536.6% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 546 | -1.8% | 0.00% | – |
| Q1 2019 | $3,000 | +50.0% | 556 | +178.0% | 0.00% | – |
| Q4 2018 | $2,000 | -71.4% | 200 | -49.0% | 0.00% | -100.0% |
| Q3 2018 | $7,000 | -76.7% | 392 | -78.1% | 0.00% | -50.0% |
| Q2 2018 | $30,000 | +233.3% | 1,786 | +100.0% | 0.00% | +100.0% |
| Q4 2017 | $9,000 | -89.5% | 893 | -88.5% | 0.00% | -85.7% |
| Q3 2017 | $86,000 | +273.9% | 7,787 | +215.4% | 0.01% | +250.0% |
| Q4 2016 | $23,000 | -32.4% | 2,469 | -29.6% | 0.00% | -33.3% |
| Q3 2016 | $34,000 | +21.4% | 3,506 | -15.7% | 0.00% | 0.0% |
| Q2 2016 | $28,000 | +250.0% | 4,159 | +367.8% | 0.00% | +200.0% |
| Q1 2016 | $8,000 | -91.9% | 889 | -90.6% | 0.00% | -90.0% |
| Q3 2015 | $99,000 | +120.0% | 9,427 | +465.2% | 0.01% | +150.0% |
| Q2 2015 | $45,000 | -45.8% | 1,668 | -38.5% | 0.00% | -60.0% |
| Q1 2015 | $83,000 | +1975.0% | 2,712 | +2612.0% | 0.01% | – |
| Q4 2014 | $4,000 | -88.9% | 100 | -90.2% | 0.00% | -100.0% |
| Q3 2014 | $36,000 | – | 1,021 | +50950.0% | 0.00% | – |
| Q2 2014 | $0 | -100.0% | 2 | -98.5% | 0.00% | -100.0% |
| Q1 2014 | $4,000 | -55.6% | 136 | -61.8% | 0.00% | -50.0% |
| Q4 2013 | $9,000 | – | 356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,773,474 | $2,376,456 | 1.12% |
| AlphaCentric Advisors LLC | 1,125,000 | $1,507,500 | 0.86% |
| Tejara Capital Ltd | 1,077,388 | $1,443,700 | 0.82% |
| Palo Alto Investors LP | 5,675,876 | $7,605,674 | 0.72% |
| Birchview Capital, LP | 571,832 | $766,255 | 0.65% |
| Altium Capital Management LP | 740,000 | $991,600 | 0.52% |
| Avidity Partners Management LP | 8,298,570 | $11,120,084 | 0.45% |
| Worth Venture Partners, LLC | 445,981 | $597,615 | 0.36% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 561,955 | $753,020 | 0.23% |
| DAFNA Capital Management LLC | 192,678 | $258,189 | 0.08% |